205 related articles for article (PubMed ID: 11009513)
1. AIDS vaccine research focuses on subtypes in developed world.
Sharma R
BMJ; 2000 Sep; 321(7264):787. PubMed ID: 11009513
[No Abstract] [Full Text] [Related]
2. AIDS vaccine 'needs focused effort' as drug firms back off research.
Butler D
Nature; 1995 Nov; 378(6555):323-4. PubMed ID: 7477355
[No Abstract] [Full Text] [Related]
3. The ethics of AIDS vaccine trials.
Macpherson CC
Science; 1998 May; 280(5368):1330; author reply 1330-1. PubMed ID: 9634406
[No Abstract] [Full Text] [Related]
4. In that case: your company has invested heavily in developing an AIDS vaccine and wishes to embark on clinical trials. Commentary.
Evans D
N Z Bioeth J; 2001 Oct; 2(3):37-8. PubMed ID: 15587008
[No Abstract] [Full Text] [Related]
5. Historical essay. Prospects for the future.
Gallo RC; Montagnier L
Science; 2002 Nov; 298(5599):1730-1. PubMed ID: 12459577
[No Abstract] [Full Text] [Related]
6. The ethics of AIDS vaccine trials.
Zion D
Science; 1998 May; 280(5368):1329-30; author reply 1330-1. PubMed ID: 9634405
[No Abstract] [Full Text] [Related]
7. A chorus of disapproval.
Nature; 2008 Jul; 454(7204):551. PubMed ID: 18668050
[No Abstract] [Full Text] [Related]
8. HIV/AIDS. Gates Foundation doubles support for AIDS vaccine research.
Cohen J
Science; 2006 Jul; 313(5785):283. PubMed ID: 16857908
[No Abstract] [Full Text] [Related]
9. A fresh injection of interest for vaccines.
AIDS Anal Afr; 1998 Feb; 8(1):3, 6. PubMed ID: 12293289
[TBL] [Abstract][Full Text] [Related]
10. HIV vaccines need to be developed: interview with Sam Avrett, International AIDS Vaccine Initiative. Interview by John S. James.
Avrett S
AIDS Treat News; 1997 May; (No 270):4-6. PubMed ID: 11364325
[TBL] [Abstract][Full Text] [Related]
11. Designing HIV vaccines for developing countries.
Abrams S
Harv AIDS Rev; 1995; ():17-9. PubMed ID: 12319991
[TBL] [Abstract][Full Text] [Related]
12. Ambitious AIDS grants deepen rift between researchers.
Basu P
Nat Med; 2006 Aug; 12(8):865. PubMed ID: 16892015
[No Abstract] [Full Text] [Related]
13. HIV/AIDS. The great funding surge.
Cohen J
Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
[No Abstract] [Full Text] [Related]
14. AIDS vaccine research. Thumbs down on expensive, hotly debated trial of NIH AIDS vaccine.
Cohen J
Science; 2008 Jul; 321(5888):472. PubMed ID: 18653850
[No Abstract] [Full Text] [Related]
15. A review of vaccines for HIV prevention.
Mwau M; McMichael AJ
J Gene Med; 2003 Jan; 5(1):3-10. PubMed ID: 12516046
[TBL] [Abstract][Full Text] [Related]
16. Ethical considerations in AIDS vaccine trials.
Mehendale S
Issues Med Ethics; 2000; 8(1):13-5. PubMed ID: 16323332
[No Abstract] [Full Text] [Related]
17. European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
Lehner T; Hoelscher M; Clerici M; Gotch F; Pedneault L; Tartaglia J; Gray C; Mestecky J; Sattentau Q; van de Wijgert J; Toure C; Osmanov S; Schmidt RE; Debre P; Romaris M; Hoeveler A; Di Fabio S
Vaccine; 2005 Dec; 23(48-49):5551-6. PubMed ID: 16153752
[TBL] [Abstract][Full Text] [Related]
18. Immunology. New virtual center aims to speed AIDS vaccine progress.
Cohen J
Science; 2005 Jul; 309(5734):541. PubMed ID: 16040673
[No Abstract] [Full Text] [Related]
19. [AIDS vaccine: who should be selected for the test?].
Marcus U
Fortschr Med; 1995 Nov; 113(32):16-7. PubMed ID: 8543269
[No Abstract] [Full Text] [Related]
20. The hunt for the AIDS vaccine.
Essex M
AIDS Asia; 1995; 2(3):10-3. PubMed ID: 12319586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
